Quality failures in generic drug manufacturing are not a compliance inconvenience. They are a market-exit event. Between 2022 and 2024, […]

A comprehensive technical guide for pharma IP teams, R&D leads, and institutional investors on translating patent surveillance into commercial advantage.

The global pharmaceutical industry in 2026 exists in a state of hyper-dynamic transition, defined by the convergence of the most

Pharmaceutical procurement teams spend enormous effort negotiating the price on a purchase order. Then they lose more money in the

Switzerland generates more patent applications per capita than any other country on earth. In 2024, the European Patent Office received

We’re excited to announce that DrugPatentWatch is now available on the Snowflake Marketplace, making it easier than ever for organizations

The global pharmaceutical sector is undergoing a massive redistribution of capital. Between 2025 and 2030, an estimated $236 billion to

Why Parallel Proceedings Matter More Than Ever Pharmaceutical patent litigation has always been expensive and slow. What changed after the

Part I: The Generic Drug Market in Numbers Global Market Size and Growth Projections The global generic drugs market was